[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354017-105":59,"doc-detail-354017-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","matrix-metalloproteinases-and-pro-inflammatory-cytokines-in-bladder-cancer-diagnostic-and-prognostic-perspectives-narrative-review","Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer - Diagnostic and Prognostic Perspectives - Narrative Review","","Bladder cancer is among the most frequently diagnosed genitourinary cancers, and its clinical variability and tendency to recur drive the search for non-invasive prognostic markers. This narrative review summarizes evidence on extracellular matrix metalloproteinases (MMPs) and pro-inflammatory cytokines in bladder cancer pathogenesis and evaluates their biomarker potential in body fluids. Reviewed studies (2012–2025) examine expression and activity of MMP-2, MMP-9, MMP-7 and MMP-1 and cytokines IL-6, IL-8, IL-17 and IFN-γ in serum, urine, and tissues.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/matrix-metalloproteinases-and-pro-inflammatory-cytokines-in-bladder-cancer-diagnostic-and-prognostic-perspectives-narrative-review/354017/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/matrix-metalloproteinases-and-pro-inflammatory-cytokines-in-bladder-cancer-diagnostic-and-prognostic-perspectives-narrative-review/354017.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which MMPs and pro-inflammatory cytokines are highlighted as potential biomarkers in bladder cancer?","Question",{"text":112,"@type":113},"The review focuses on MMP-2, MMP-9, MMP-7 and MMP-1, and cytokines IL-6, IL-8, IL-17 and IFN-γ, assessed in serum, urine, and tumor tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do MMPs relate to tumor progression in bladder cancer?",{"text":117,"@type":113},"MMPs are described as key contributors to extracellular matrix degradation, supporting invasion, angiogenesis, and metastasis, with elevated MMP-2 and MMP-9—especially in urine—linked to clinical stage and malignancy grade.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are further prospective studies needed?",{"text":121,"@type":113},"Although the data support biomarker promise, the review notes a need for additional multicentre prospective studies to validate findings and standardize determination methods.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354017,1790644407,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Review  \nMatrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer: Diagnostic and Prognostic Perspectives: Narrative Review  \nUrszula Lipka, Karolina Orywal  and Monika Gudowska-Sawczuk *  \nAcademic Editor: Sung-Kun (Sean) Kim  \nReceived: 6 March 2026  \nRevised: 27 March 2026  \nAccepted: 31 March 2026  \nPublished: 2 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland  \n* [Correspondence: monika.gudowska-sawczuk@umb.edu.pl](Correspondence: monika.gudowska-sawczuk@umb.edu.pl); Tel.: +48-85-831-8703  \nAbstract  \nBladder cancer (BC) is one of the most commonly diagnosed cancers of the genitourinary system and ranks ninth in terms of incidence worldwide. Due to the varied clinical course of the disease and the frequent tendency for tumor recurrence, diagnostic studies are being conducted to find non-invasive and prognostic markers that could be helpful in diagnosing BC. The aim of this review was to present the current state of knowledge on the role of extracellular matrix metalloproteinases (MMPs) and pro-inflammatory cytokines in the pathogenesis of bladder cancer, as well as to assess their potential as biomarkers measured in body fluids. The study reviewed the literature published in English between 2012 and 2025 . The studies included clinical and experimental research analysing the expression and activity of selected metalloproteinases, including MMP-2, MMP-9, MMP-7 and MMP-1, and pro-inflammatory cytokines such as interleukins (ILs): IL-6, IL-8, IL-17, and IFN-γ in serum, urine, and tumor tissues of patients with BC, using immunochemical methods and genetic analyses. The collected data indicate that MMPs play a key role in the degradation of the extracellular matrix, facilitating invasion, angiogenesis, and metastasis. Elevated concentrations of MMP-2 and MMP-9, especially in urine, correlate with the clinical stage and histopathological malignancy of the tumor. MMP-7 may be important in the early stages of carcinogenesis, while MMP-1 shows promising potential in multimarker panels. At the same time, chronic inflammation and increased pro-inflammatory cytokine activity play a key role in modulating the tumor microenvironment. IL-6 and IL-8 have high diagnostic value in urine tests, with IL-6 also serving as a prognostic marker. IL-17 is associated with more aggressive forms of the disease, while IFN-γ may reflect the immune response to BC treatment. There is also evidence of positive feedback between cytokines and MMPs, which intensifies the process of tumor invasion and progression. Therefore, both extracellular matrix metalloproteinases and pro-inflammatory cytokines may be promising non-invasive biomarkers of bladder cancer. Their combined assessment can increase the diagnostic and prognostic value compared to the analysis of individual parameters. However, further multicentre prospective studies are needed for clinical validation and standardisation of the methods of determination.  \nKeywords: matrix metalloproteinases; MMP; cytokines; bladder cancer; diagnosis; prognosis; marker; inflammation  \n1. Introduction  \nBladder cancer (BC) is the most common genitourinary malignancy and the ninth most diagnosed cancer worldwide. About 430,000 new cases are diagnosed yearly, with incidence rising mainly in developed countries [1,2] . The risk of developing bladder cancer is higher in men, with an age-standardized rate (ASR) ratio ranging from 6:1 to 2:1 depending on the latitude and place of residence [3] . The risk of the disease also increases with age. A predisposing factor for the development of cancer is exposure to carcinogens through direct contact with the skin, respiratory tract, and digestive system. The most important fa","cbCaioxAL366tuMo","https://ap.wps.com/l/cbCaioxAL366tuMo","pdf",632928,15,"English","# 1. Introduction\n## Bladder cancer epidemiology and risk factors\n## Current diagnostic approaches and limitations\n## Role of molecular markers","[{\"question\":\"Which MMPs and pro-inflammatory cytokines are highlighted as potential biomarkers in bladder cancer?\",\"answer\":\"The review focuses on MMP-2, MMP-9, MMP-7 and MMP-1, and cytokines IL-6, IL-8, IL-17 and IFN-γ, assessed in serum, urine, and tumor tissues.\"},{\"question\":\"How do MMPs relate to tumor progression in bladder cancer?\",\"answer\":\"MMPs are described as key contributors to extracellular matrix degradation, supporting invasion, angiogenesis, and metastasis, with elevated MMP-2 and MMP-9—especially in urine—linked to clinical stage and malignancy grade.\"},{\"question\":\"Why are further prospective studies needed?\",\"answer\":\"Although the data support biomarker promise, the review notes a need for additional multicentre prospective studies to validate findings and standardize determination methods.\"}]","Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer - Diagnostic and Prognostic Perspectives - Narrative Review | PDF",1790108484,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42fc04f9eb460464700f5585150edbe6.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5f8b9cf85693b450d3687da50465151.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/639d5bb3aa2a7d8a93e95cc8ccf039a4.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3284c514bd19b433f20b342749feb09c.webp",980,1385]